Cryptococcemia in a patient with COVID‐19: A case report
Mohamad Khatib, Amna Ahmed, Said B. Shaat, Ahmed S. Mohamed, Abdulqadir J. Nashwan
Abstract
The authors urge clinicians to balance the use of Immunosuppressant drugs and tocilizumab for COVID-19 patients to avoid the development of infections like Cryptococcemia, leading to death within 30 days.
Topics & Concepts
MedicineTocilizumabCoronavirus disease 2019 (COVID-19)Intensive care medicine2019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Internal medicineVirologyDiseaseInfectious disease (medical specialty)OutbreakFungal Infections and StudiesAntifungal resistance and susceptibilityNail Diseases and Treatments